| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/30/2013 | EP2551270A2 Pyrazolopyrmidine derivatives for use as pi3 kinase antagonists |
| 01/30/2013 | EP2551255A1 Cannabinoid quinone derivatives |
| 01/30/2013 | EP2550976A2 Modulator compounds of the drug resistance in epithelial tumour cells |
| 01/30/2013 | EP2550975A1 Combination therapy for the treatment of CD19+ B-cell malignancies symptoms comprising an anti-CD19 maytansinoid immunoconjugate and rituximab |
| 01/30/2013 | EP2550972A1 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/30/2013 | EP2550360A1 Bivalent antisense oligonucleotides |
| 01/30/2013 | EP2550298A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 01/30/2013 | EP2550295A1 Anti-lrp6 antibodies |
| 01/30/2013 | EP2550294A2 Prophylaxis of colorectal and gastrointestinal cancer |
| 01/30/2013 | EP2550285A1 Trioxacarcins and uses thereof |
| 01/30/2013 | EP2550275A1 Pyrrolo[2,l-c][l,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety and process for the preparation thereof |
| 01/30/2013 | EP2550266A2 Heterocyclic compounds useful for kinase inhibition |
| 01/30/2013 | EP2550258A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/30/2013 | EP2550257A1 Pharmaceutically active disubstituted triazine derivatives |
| 01/30/2013 | EP2550254A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 01/30/2013 | EP2550010A1 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 01/30/2013 | EP2550008A2 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer |
| 01/30/2013 | EP2549990A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 01/30/2013 | EP2549868A1 Chemical compounds |
| 01/30/2013 | EP2406206B1 Tetrahydronaphthalen-2-ol derivatives |
| 01/30/2013 | CN1919328B Chinese medicinal compound formulation of anticancer zanthoxylum and curcuma zedoaria |
| 01/30/2013 | CN102906118A Biological materials related to HER3 |
| 01/30/2013 | CN102906117A Anti-LRP6 antibodies |
| 01/30/2013 | CN102906095A Pyrrolopyrazine derivatives as SYK and JAK inhibitors |
| 01/30/2013 | CN102906092A Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |
| 01/30/2013 | CN102906090A 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
| 01/30/2013 | CN102906086A Quinazoline compounds |
| 01/30/2013 | CN102906074A Fused imidazole derivative |
| 01/30/2013 | CN102905763A Lipids, lipid compositions, and methods of using them |
| 01/30/2013 | CN102905721A Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 01/30/2013 | CN102905713A A novel method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer |
| 01/30/2013 | CN102905709A Egfr inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer |
| 01/30/2013 | CN102905705A Novel iridium/rhodium anti-cancer compounds |
| 01/30/2013 | CN102905703A Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases, etc. |
| 01/30/2013 | CN102905700A Compositions and methods for the prevention and treatment of cancer |
| 01/30/2013 | CN102905693A Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids |
| 01/30/2013 | CN102905534A Methods of treating cancer |
| 01/30/2013 | CN102902895A Compound for preventing and treating human papillomavirus infection disease and screening method of compound |
| 01/30/2013 | CN102901826A New potential human cytokine TMEM98 and uses thereof |
| 01/30/2013 | CN102899343A Gene vector system, its preparation and application |
| 01/30/2013 | CN102899327A Antiviral small nucleic acid and temperature-sensitive type gel preparation and application thereof |
| 01/30/2013 | CN102899325A Small interfering RNA for TRAPPC4 gene target point, and uses thereof |
| 01/30/2013 | CN102899261A Isolated bifidobacterium longum subsp. longum capable of producing high cell immunity reaction |
| 01/30/2013 | CN102898641A Single active functional group-containing Y-type polyethylene glycol and preparation method thereof |
| 01/30/2013 | CN102898543A Water-soluble carbon nanotube and application thereof |
| 01/30/2013 | CN102898542A Water-soluble fullerene and application thereof |
| 01/30/2013 | CN102898538A Abalone viscera acidic polysaccharose and health-care product containing abalone viscera acidic polysaccharose and application of abalone viscera acidic polysaccharose |
| 01/30/2013 | CN102898528A Calreticulin-soluble programmed death receptor 1 fusion protein, and preparation method and purpose thereof |
| 01/30/2013 | CN102898527A Pharmaceutical composition for preventing or treating cancer |
| 01/30/2013 | CN102898526A Tumor necrosis factor-related apoptosis-inducing ligand fusion protein, its preparation and application |
| 01/30/2013 | CN102898524A Human-mouse chimeric antibody of anti-human tumor necrosis factor related apoptosis-inducing ligand receptor DR5, preparation method and uses thereof |
| 01/30/2013 | CN102898523A N-substituted-tetrahydropyridylindole-monoclonal antibody CD14 conjugates, and preparation method and application thereof |
| 01/30/2013 | CN102898522A Tetrahydropyridinopyran-monoclonal antibody CD14 conjugate with anti-tumor activity and preparation method and use thereof |
| 01/30/2013 | CN102898508A Polypeptide for enclosing TGF-beta acceptor or IL-10 acceptor, pharmaceutical composition and application |
| 01/30/2013 | CN102898502A Coumarin derivative, and its preparation method and application |
| 01/30/2013 | CN102898499A Benzopyran triterpene, medicinal composition thereof and preparation method and application of benzopyran triterpene |
| 01/30/2013 | CN102898496A Preparation method for oleanolic acid type saponin |
| 01/30/2013 | CN102898489A Rebeccamycin analogue with anticancer activity and synthetic method thereof |
| 01/30/2013 | CN102898478A High efficiency telomerase inhibitor and application of telomerase inhibitor in antitumor drug |
| 01/30/2013 | CN102898463A 2-hydroxy-N-(2-hydroxybenzoyl) benzo-hydrazide dibutyl tin complex and preparation method and application thereof |
| 01/30/2013 | CN102898433A Tetrandrine gallate and drug composition, preparation method and applications thereof |
| 01/30/2013 | CN102898426A Pyrazolopyridine derivatives for inhibiting activity of insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase |
| 01/30/2013 | CN102898424A Novel polymorphs of dasatinib, and preparation method thereof |
| 01/30/2013 | CN102898416A 5-substituted quinazolinone derivatives as anti-cancer agents |
| 01/30/2013 | CN102898412A Anti-tumor and anti-bacterial dodecacyclo lactone compounds and use thereof |
| 01/30/2013 | CN102898408A Benzopyran compounds, preparation method and applications thereof |
| 01/30/2013 | CN102898402A Benzisoselenazolone-modified pyrrolyl formate-substituted indolone compound and use thereof |
| 01/30/2013 | CN102898386A Quinazoline derivative, preparation method, intermediate, composition and application |
| 01/30/2013 | CN102898381A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898380A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898379A N-(4-(4-(3-chlorphenyl)piperazino-1-yl)pyrimidyl-2-yl)amide or its salts, and preparation method and use thereof |
| 01/30/2013 | CN102898378A Phthalazinone derivatives and application thereof |
| 01/30/2013 | CN102898377A Novel phthalazinone derivatives and uses thereof |
| 01/30/2013 | CN102898371A Chiral polycyclic piperidine derivative, synthetic method and application |
| 01/30/2013 | CN102898364A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/30/2013 | CN102898363A Carbamate compound and application thereof in antitumor drug |
| 01/30/2013 | CN102898362A Preparation method and applications of derivatives containing nicotinic acids and acetylsalicylic acid curcumin |
| 01/30/2013 | CN102898349A Solid containing compound, a composition containing the solid and use of the solid |
| 01/30/2013 | CN102898332A Hydroxamic acid derivative, its pharmaceutical composition, preparation method and application |
| 01/30/2013 | CN102898330A Colchicine derivative |
| 01/30/2013 | CN102898284A 3-allyl-[1,1'-biphenyl]-4-phenol, derivatives, preparation methods and uses thereof |
| 01/30/2013 | CN102895672A Composition for treating cancers and use thereof |
| 01/30/2013 | CN102895670A Water-soluble molecular target porphin photosensitizer and preparation method thereof |
| 01/30/2013 | CN102895669A Cis-platinum complex and preparation method thereof |
| 01/30/2013 | CN102895667A Method for preparing lactobionic acid-crosslinked hepatic cell targeted viral vector |
| 01/30/2013 | CN102895665A Preparation method of targeting graphene nano-grade drug carrier |
| 01/30/2013 | CN102895663A Compositions containing EGFL 7 antagonist for modulating vascular development and methods |
| 01/30/2013 | CN102895662A Composition for chemoembolotherapy of solid tumors |
| 01/30/2013 | CN102895622A Preparation technology and production method for integrated new formulation of sun spurge decoction |
| 01/30/2013 | CN102895621A Preparation technology and production method for integrated new formulation of turtle shell decocted pill |
| 01/30/2013 | CN102895605A Traditional Chinese medicine (TCM) preparation for treating hysteromyoma and preparation method |
| 01/30/2013 | CN102895596A Traditional Chinese medicine for treating breast cancer through oral medication |
| 01/30/2013 | CN102895523A Extraction method of Pseudobulbus Cremastrae seu Pleiones extracts |
| 01/30/2013 | CN102895497A Preparation technology and production method for integrated new formulation of lily and radix rehmanniae decoction |
| 01/30/2013 | CN102895414A Chinese herbal paste for treating superficial cancer |
| 01/30/2013 | CN102895395A Preparation technology and production method for integrated new formulation of rhubarb and eupolnhagea pill |
| 01/30/2013 | CN102895323A Method for extracting buckwheat flavonoid |
| 01/30/2013 | CN102895298A Preparation technology and production method for integrated new formulation of Chinese sage herb decoction |
| 01/30/2013 | CN102895290A Preparation technology and production method for integrated new formulation of snakegourd root and oyster powder |
| 01/30/2013 | CN102895280A Cancer cell inhibiting medicament |